James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $552.78 ($5.6M) on 2026-04-06, disclosed to the SEC on 2026-04-07.
Scheduled sale ($5.6M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $552.78 | 120 | $66K | 1.2% |
| 2 | $553.97 | 437 | $242K | 4.3% |
| 3 | $555.21 | 1,158 | $643K | 11.5% |
| 4 | $556.06 | 1,205 | $670K | 12.0% |
| 5 | $557.19 | 1,840 | $1.0M | 18.4% |
| 6 | $558.31 | 1,679 |
| $937K |
| 16.8% |
| 7 | $559.47 | 860 | $481K | 8.6% |
| 8 | $560.18 | 616 | $345K | 6.2% |
| 9 | $561.56 | 645 | $362K | 6.5% |
| 10 | $562.75 | 619 | $348K | 6.2% |
| 11 | $563.47 | 539 | $304K | 5.4% |
| 12 | $564.43 | 82 | $46K | 0.8% |
| 13 | $566.01 | 200 | $113K | 2.0% |
| Total | $558.40 avg | 10,000 | $5.6M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |